250 related articles for article (PubMed ID: 32281034)
1. Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
Hirose C; Fujii H; Iihara H; Ishihara M; Nawa-Nishigaki M; Kato-Hayashi H; Ohata K; Sekiya K; Kitahora M; Matsuhashi N; Takahashi T; Okuda K; Naruse M; Ishihara T; Sugiyama T; Yoshida K; Suzuki A
Support Care Cancer; 2020 Dec; 28(12):5943-5952. PubMed ID: 32281034
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.
Fujii H; Ueda Y; Hirose C; Ohata K; Sekiya K; Kitahora M; Sadaka S; Yamamoto S; Watanabe D; Kato-Hayashi H; Iihara H; Kobayashi R; Kaburaki M; Matsuhashi N; Takahashi T; Makiyama A; Yoshida K; Hayashi H; Suzuki A
J Pharm Health Care Sci; 2022 Mar; 8(1):8. PubMed ID: 35236407
[TBL] [Abstract][Full Text] [Related]
3. Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study.
Fujii H; Koda M; Sadaka S; Ohata K; Kato-Hayashi H; Iihara H; Kobayashi R; Ishihara T; Uemura S; Iwashita T; Hayashi H; Sugiyama T; Shimizu M; Suzuki A
J Pharm Health Care Sci; 2021 Aug; 7(1):27. PubMed ID: 34334136
[TBL] [Abstract][Full Text] [Related]
4. Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan.
Tanaka S; Ando K; Kobayashi K; Seki T; Hamada T; Machino M; Ota K; Morozumi M; Kanbara S; Ito S; Ishiguro N; Hasegawa Y; Imagama S
Nagoya J Med Sci; 2020 Feb; 82(1):5-14. PubMed ID: 32273627
[TBL] [Abstract][Full Text] [Related]
5. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.
Sawada A; Hiragi S; Tamura H; Goto R; Matsuyama Y; Sakai K; Miyata H; Yanagita M; Kuroda T; Ogawa O; Kobayashi T
Transplant Proc; 2021 Apr; 53(3):881-884. PubMed ID: 33303208
[TBL] [Abstract][Full Text] [Related]
7. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
8. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Hino A; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Noto S; Shimozuma K
Qual Life Res; 2019 Sep; 28(9):2383-2391. PubMed ID: 31025290
[TBL] [Abstract][Full Text] [Related]
9. Correlation of preference- and profile-based quality of life of Japanese oral cancer patients during the perioperative period measured using EQ-5D-5L and FACT-H&N.
Aoki T; Ota Y; Izawa K; Osawa Y; Seta S; Tsuda B
Int J Oral Maxillofac Surg; 2022 Aug; 51(8):992-999. PubMed ID: 34551875
[TBL] [Abstract][Full Text] [Related]
10. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
11. Quality assessment using EQ-5D-5L after lung surgery for non-small cell lung cancer (NSCLC) patients.
Koide R; Kikuchi A; Miyajima M; Mishina T; Takahashi Y; Okawa M; Sawada I; Nakajima J; Watanabe A; Mizuguchi T
Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1056-1061. PubMed ID: 31098867
[TBL] [Abstract][Full Text] [Related]
12. Walking ability, anxiety and depression, significantly decrease EuroQol 5-Dimension 5-Level scores in older hemodialysis patients in Japan.
Shimizu U; Aoki H; Sakagami M; Akazawa K
Arch Gerontol Geriatr; 2018; 78():96-100. PubMed ID: 29936330
[TBL] [Abstract][Full Text] [Related]
13. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
[TBL] [Abstract][Full Text] [Related]
14. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
15. Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients.
Mugii N; Someya F; Noto S; Hamaguchi Y; Matsushita T; Takehara K
Mod Rheumatol; 2020 Jul; 30(4):681-686. PubMed ID: 31269847
[No Abstract] [Full Text] [Related]
16. Validity of the EQ-5D-5L and reference norms for the Spanish population.
Hernandez G; Garin O; Pardo Y; Vilagut G; Pont À; Suárez M; Neira M; Rajmil L; Gorostiza I; Ramallo-Fariña Y; Cabases J; Alonso J; Ferrer M
Qual Life Res; 2018 Sep; 27(9):2337-2348. PubMed ID: 29767329
[TBL] [Abstract][Full Text] [Related]
17. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
Martin A; Meads D; Griffiths AW; Surr CA
Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
[TBL] [Abstract][Full Text] [Related]
18. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
[TBL] [Abstract][Full Text] [Related]
19. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of utility index of quality of life (QOL) in prostate cancer patients: comparison of QOL utility index EuroQol-5D (EQ-5D) and visual analogue scale (VAS) with health-related QOL questionnaires SF-36 and EPIC].
Akakura K; Matsuzaki K; Kobayashi T; Kitoh H; Mizoguchi K; Tomikawa G; Takura T; Kawabuchi K
Nihon Hinyokika Gakkai Zasshi; 2011 Jan; 102(1):9-13. PubMed ID: 21520631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
